-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bemcentinib in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bemcentinib in Relapsed Acute Myeloid Leukemia Drug Details: Bemcentinib (BGB-324, R-428) is under development for...
-
Product Insights
Human Papillomavirus (HPV) Associated Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Drugs In Development, 2023’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Oropharyngeal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Oropharyngeal Cancer - Drugs In Development, 2023’, provides an overview of the Oropharyngeal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMV-002 in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMV-002 in Head And Neck Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AMV-002 in Head And Neck Cancer Drug Details:AMV-002 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC)Drug Details:Casdozokitug (SRF-388) is under development...
-
Product Insights
Surgical Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Surgical Heart Valves Pipeline Market Report Overview Surgical heart valves are used in cardiac surgeries to treat heart valves diseases where the affected heart valves are either replaced or repaired. Cardiac valve repair devices and prosthetic heart valves are covered under this category. The surgical heart valves pipeline market research report provides comprehensive information about the surgical heart valves pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Product Insights
Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Prosthetic Heart Valves Pipeline Market Report Overview Prosthetic heart valves is a device which mimics the function of human heart valves and have a passive mode of functioning; opening and closing of valves are responses to pressure and flow changes within the heart. They are for the patients that have a heart valvular disease where they need their valve to be replaced. The Prosthetic Heart Valves pipeline market research report provides comprehensive information about the Prosthetic Heart Valves pipeline products...
-
Product Insights
Transcatheter Valve Delivery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transcatheter Valve Delivery Devices Pipeline Market Report Overview Transcatheter Valve Delivery Devices are designed to deliver heart valves using the minimally invasive heart procedures. The Transcatheter Valve Delivery Devices pipeline market research report provides comprehensive information about the Transcatheter valve delivery devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Company Profile
Anteris Technologies Ltd – Company Profile
Anteris Technologies Ltd (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bio scaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve opening and better blood flow. Anteris Technologies is headquartered in Brisbane, Queensland, Australia.
Add to Basket -
Product Insights
NewAnteris Technologies Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Anteris Technologies Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Anteris Technologies Ltd, (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bio scaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve...